Skip to main content
SpringerLink
Log in

Does the mutational status affect the bone marrow morphological findings in patients with classical Philadelphia-negative myeloproliferative neoplasms?

  • Letter to the editor
  • Published:
Journal of Hematopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405

    Article  CAS  PubMed  Google Scholar 

  2. Pozdnyakova O, Hasserjian RP, Verstovsek S, Orazi A (2015) Impact of bone marrow pathology on the clinical management of Philadelphia chromosome-negative myeloproliferative neoplasms. Clin Lymphoma Myeloma Leuk 15:253–261

    Article  PubMed  Google Scholar 

  3. Tefferi A (2010) Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 24:1128–1138

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD et al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369:2379–2390

    Article  CAS  PubMed  Google Scholar 

  5. Alvarez-Larrán A, Ancochea A, Garcia M, Climent F, García-Pallarols F, Angona A et al (2014) WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes. Br J Haematol 166:911–919

    Article  PubMed  Google Scholar 

  6. Rumi E, Pietra D, Pascutto C, Guglielmelli P, Martínez-Trillos A, Casetti I et al (2014) Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis. Blood 124:1062–1069

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kim SY, Im K, Park SN, Kwon J, Kim JA, Lee DSCALR (2015) JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable. Am J Clin Pathol 143:635–644

    Article  CAS  PubMed  Google Scholar 

  8. Loghavi S, Bueso-Ramos CE, Kanagal-Shamanna R, Ok CY, Salim AA, Routbort MJ et al (2016) Myeloproliferative neoplasms with calreticulin mutations exhibit distinctive morphologic features. Am J Clin Pathol 145:418–427

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Analysis, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Canary Islands, Spain

    L. Medina-Vega

  2. Department of Hematology, Hospital Universitario de Canarias, Universidad de La Laguna, 38320 La Laguna, Tenerife, Canary Islands, Spain

    L. Hernández-Nieto & J. M. Raya

  3. Department of Pathology, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Canary Islands, Spain

    H. Álvarez-Argüelles & E. Salido

Authors
  1. L. Medina-Vega
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Hernández-Nieto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Álvarez-Argüelles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Salido
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. M. Raya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. M. Raya.

Ethics declarations

Conflict of interests

The authors do not have any conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Medina-Vega, L., Hernández-Nieto, L., Álvarez-Argüelles, H. et al. Does the mutational status affect the bone marrow morphological findings in patients with classical Philadelphia-negative myeloproliferative neoplasms?. J Hematopathol 10, 141–143 (2017). https://doi.org/10.1007/s12308-017-0307-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12308-017-0307-x

Search

Navigation